Retrospective study of erlotinib in patients with advanced squamous lung cancer

JS Tseng, TY Yang, KC Chen, KH Hsu, HY Chen… - Lung Cancer, 2012 - Elsevier
Background: The effective targeted therapy for lung squamous cell carcinoma (SCC) is
needed. The epidermal growth factor receptor (EGFR) mutation rate is low in lung SCC. The …
被引用次数：42 相关文章

Retrospective study of erlotinib in patients with advanced squamous lung cancer

JS Tseng, TY Yang, KC Chen, KH Hsu… - Lung …, 2012 - lungcancerjournal.info
Background: The effective targeted therapy for lung squamous cell carcinoma (SCC) is
needed. The epidermal growth factor receptor (EGFR) mutation rate is low in lung SCC. The …

Retrospective study of erlotinib in patients with advanced squamous lung cancer.

JS Tseng, TY Yang, KC Chen, KH Hsu… - Lung Cancer …, 2012 - europepmc.org
Background The effective targeted therapy for lung squamous cell carcinoma (SCC) is
needed. The epidermal growth factor receptor (EGFR) mutation rate is low in lung SCC. The …

Retrospective study of erlotinib in patients with advanced squamous lung cancer

JS Tseng, TY Yang, KC Chen… - Lung cancer …, 2012 - pubmed.ncbi.nlm.nih.gov
Background The effective targeted therapy for lung squamous cell carcinoma (SCC) is
needed. The epidermal growth factor receptor (EGFR) mutation rate is low in lung SCC. The …

Retrospective study of erlotinib in patients with advanced squamous lung cancer

JS Tseng, TY Yang, KC Chen, KH Hsu, HY Chen… - Lung Cancer, 2012 - infona.pl
Background: The effective targeted therapy for lung squamous cell carcinoma (SCC) is
needed. The epidermal growth factor receptor (EGFR) mutation rate is low in lung SCC. The …

[引用][C] Retrospective study of erlotinib in patients with advanced squamous lung cancer

JS TSENG, TY YANG, KC CHEN, KH HSU… - Lung …, 2012 - pascal-francis.inist.fr
Retrospective study of erlotinib in patients with advanced squamous lung cancer CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …